Abstract
The wounds are infected by one or more bacteria or other microbes. The occurrence of the bacterial infections in wounds is mainly responsible in delayed healing and enhancement of wound. These bacteria include Gram-positive bacteria such as Streptococcus pyogenes, Enterococcus faecalis, Staphylococcus aureus, and Gram-negative bacteria including Pseudomonas aeruginosa, Escherichia coli, Klebsiella species, and fungi like Candida and Aspergillus. The use of silver has been known since nineteenth century and after the discovery of penicillin, its use was reduced. However, the occurrence of multidrug-resistant bacteria has led to the search of new antibiotics and alternatives to solve the problem of multidrug-resistance. In this context, scientists have shown much interest on the use of silver and silver nanoparticles as they are very effective against bacterial infections.
This chapter is aimed to discuss the role of silver and silver nanoparticles in wound infections. In addition, the resistance of microbes to silver and silver nanoparticles and the toxicity issues have also been addressed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmadi M, Adibhesami M (2017) The effect of silver nanoparticles on wounds contaminated with Pseudomonas aeruginosa in mice: an experimental study. Iran J Pharm Res 16(2):661–669
Alavi M, Rai M (2019) Recent advances in antibacterial applications of metal nanoparticles (MNPs) and metal nanocomposites (MNCs) against multidrug-resistant (MDR) bacteria. Expert Rev Anti-Infect Ther 17(6):419–428. https://doi.org/10.1080/14787210.2019.1614914
Atiyeh BS, Costagliola M, Hayek SN, Dibo SA (2007) Effect of silver on burn wound infection control and healing: review of literature. Burns 33:139–148
Ayton M (1985) Wound care: wounds that won’t heal. Nurs Times 81(46):16–19
Barillo DJ, Marx DE (2014) Silver in medicine: a brief history BC 335 to present. Burns 40:3–8
Bawskar MS, Deshmukh SD, Bansod S, Gade AK, Rai MK (2015) Comparative analysis of biosynthesised and chemosynthesised silver nanoparticles with special reference to their antibacterial activity against pathogens. IET Nanobiotechnol 9(3):107–113
Birla SS, Tiwari VV, Gade AK, Ingle AP, Yadav AP, Rai MK (2009) Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Lett Appl Microbiol 48(2):173–179
Bonde SR, Rathod DP, Ingle AP, Ade RB, Gade AK, Rai MK (2012) Murraya koenigii-mediated synthesis of silver nanoparticles and its activity against three human pathogenic bacteria. Nanosci Methods 1:25–36
Bowler PG (1998) The anaerobic and aerobic microbiology of wounds: A review. Wounds 10(6):170–178
Bowler P, Duerden B, Armstrong D (2001) Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14(2):244–269
Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC (2005) In vitro cytotoxicity of nanoparticles in mammalian gemline stem cells. Toxicol Sci 88(2):412–419
Bridges K, Kidson A, Lowbury EJ et al (1979) Gentamicin—and silver—resistant Pseudomonas in a burns unit. Br Med J 1:446–449
Burd A, Kwok CH, Hung SC, Chan HS, Gu H, Lam WK, Huang L (2007) A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen 15:94–104
Burrell RE (2003) A scientific perspective on the use of topical silver preparations. Ostomy Wound Manage 49(Suppl. 5A):19–24
Calvin M (1998) Cutaneous wound repair. Wounds 10(1):12–32
Chopra I (2007) The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J Antimicrob Chemother 59:587–590
Chu CS, McManus AT, Pruitt BA Jr, Mason AD Jr (1988) Therapeutic effects of silver nylon dressings with weak current on Pseudomonas aeruginosa—infected burn wounds. J Trauma 28:1488–1492
Chu CS, McManus AT, Okerberg CV, Mason AD Jr, Pruitt BA Jr (1991) Weak direct current accelerates split-thickness graft healing on tangentially excised second degree burns. J Burn Care Rehabil 12:285–293
Chu CS, Matylevich NP, McManus AT, Masson AD Jr, Pruitt BA Jr (1996) Direct current reduces wound edema after full thickness burn injury in rats. J Trauma 40(5):738–742
Collier M (2004) Recognition and management of wound infection. J World Wide Wounds
Dunn K, Edwards-Jones V (2004) The role of Acticoat with nanocrystalline silver in the management of burns. Burns 30:1–9
Fakhry SM, Alexander J, Smith D, Meyer AA, Petterson HD (1995) Regional and institutional variation in burn care. J Burn Care Rehabil 16:86–90
Falanga V, Grinnell F, Gilchrest B, Maddox YT, Moshell A (1994) Workshop on the pathogenesis of chronic wounds. J Invest Dermatol 102(1):125–127
Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO (2000) A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 52(4):662–668
Fong J, Wood F, Fowler BA (2005) A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits. Burns 31(5):562–567
Fox CL (1968) Silver sulfadiazine—a new topical agent. Arch Surg 96:184–188
Fox CL, Stanford JW (1971) Anti-bacterial action of silver sulphadiazine and DNA binding. In: Matter P, Barcaly TL, Konikova Z (eds) Research in burns. Huber, Bern, pp 133–138
Franci G, Falanga A, Galdiero S, Palomba L, Rai M, Morelli G, Galdiero M (2015) Silver nanoparticles as potential antibacterial agents. Molecules 20:8856–8874. https://doi.org/10.3390/molecules20058856
Gajbhiye M, Kesharwani J, Ingle A, Gade A, Rai M (2009) Fungal-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole. Nanomedicine 5(4):382–386
Gamelli RL, Paxton TP, O’Reilly M (1993) Bone marrow toxicity by silver sulphadiazine. Surg Gynec Obstet 177:115–120
Jiang B, Larson JC, Drapala PW, Perez-Luna VH, Kang-Mieler JJ, Brey EM (2012) Investigation of lysine acrylate containing poly(N-isopropylacrylamide) hydrogels as wound dressings in normal and infected wounds. J Biomed Mater Res 100:668–676
Karkman A, Katariina P, Joakim Larsson DG (2019) Fecal pollution can explain antibiotic resistance gene abundances in anthropogenically impacted environments. Nat Commun 0:80. https://doi.org/10.1038/s41467-018-07992-3
Kedi PBE, Meva FE, Kotsedi L, Nguemfo EL, Zangueu CB, Ntoumba AA, Mohamed HEA, Dongmo AB, Maaza M (2018) Eco-friendly synthesis, characterization, in vitro and in vivo anti-inflammatory activity of silvernanoparticle-mediated Selaginella myosurus aqueous extract. Int J Nanomedicine 12(13):8537–8548. https://doi.org/10.2147/IJN.S174530.
Kingsley A (2001) A proactive approach to wound infection. Nurs Stand 15(30):50–54, 56, 58
Kirsner R, Orsted H, Wright B (2001) Matrix metalloproteinases in normal and impaired wound healing: a potential role of nanocrystaline silver. Wounds 13:5–10
Klasen HJ (2000) A historical review of the use of silver in the treatment of burns. Part I early uses. Burns 30:1–9
Klueh U, Wagner V, Kelly S, Johnson A, Bryers JD (2000) Efficacy of silver coated fabric to prevent bacterial colonization and subsequent device-based biofilm formation. J Biomed Mater Res 53:621–631
Lansdown ABG (2006) Silver in health care: antimicrobial effects and safety in use. Cuur Probl Dermatol 33:17–34. In: Biofunctional Textiles and the Skin, Hipler U.C., Elsner P. (eds)
Lansdown ABG (2010) Silver in health and disease. Its antimicrobial efficacy and safety in use. Royal Society of Chemistry, London
Li XZ, Nikaido H, Williams KE (1997) Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins. J Bacteriol 179:6127–6132
Liau SY, Read DC, Pugh WJ, Furr JR, Russel AD (1997) Interaction of silver-nitrate with readily identiflabe groups-relationship to the antibacterial action of silver ions. Lett Appl Microbiol 25:279–283
Liu X, Lee P, Ch H, Lui V, Chen Y, Ch C, Tam P, Wong KY (2010) Silver nanoparticles mediate differential responses in keratinocytes and fibroblasts during skin wound healing. ChemMedChem 5(3):468–475
McHugh GL, Moellering RC, Hopkins CC et al (1975) Salmonella typhimurium resistant to silver nitrate, chloramphenicol and ampicillin. Lancet 1:235–240
Mooney EK (2006) Silver dressings (safety and efficacy reports). Plast Reconstr Surg 117(2):666–669
Moyer CA, Brentano L, Gravens DL, Margraf HW, Monafo WW (1965) Treatment of large human burns with 0.5% silver nitrate solution. Arch Surg 90:812–867
Nadworny PL, Wang JF, Tredget EE, Burrell RE (2010) Anti-inflammatory activity of nanocrystalline silver-derived solutions in porcine contact dermatitis. J Inflam 7:20
Nam G, Rangasamy S, Purushothaman B, Song JM (2015) The application of bactericidal silver nanoparticles in wound treatment. Nanomater Nanotechnol 5:23
Pal S, Tak YK, Song JM (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73(6):1712–1720
Poon VKM, Burd A (2004) In vitro cytotoxity of silver: implication for clinical wound care. Burns 30:140–147
Prabhu S, Poulose EK (2012) Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical application, and toxicity effects. Int Nano Lett 2:32–42
Rai MK, Yadav AP, Gade AK (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27(1):76–83
Rai MK, Deshmukh SD, Ingle AP, Gade AK (2012) Silver nanoparticles: powerful nanoweapon against multidrug-resistant bacteria. Appl Microbiol 112:841–852
Robson MC (1997) Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin N Am 77:637–650
Shrivastava S, Bera T, Poy A, Singh G, Ramachandrarao P, Dash D (2007) Characterisation of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 18:1–9
Singh J, Dutta T, Kim K, Rawat M, Samddar P, Kumar P (2018) Green’ synthesis of metals and their oxide nanoparticles: applications for environmental remediation. J Nanobiotechnol 16:84. https://doi.org/10.1186/s12951-018-0408-4
Stanford W, Rappole BW, Fox Jr CL (1969) Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infection in burn patients. J Trauma 9(5):377–388
Tian J, Wong KK, Ho CM, Lok CN, Yu WY, Che CM et al (2007) Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2:129–136
Tredget EE, Shankowsky HA, Groeneveld A, Burrell R (1998) A matched – pair, randomized study evaluating the efficacy and safety of Acticoat silver – coated dressing for the treatment of burn wounds. J Burn Care Rehabil 19:531–537
Venkataraman M, Nagarsenker M (2013) Silver sulfadiazine nanosystems for burn therapy. AAPS PharmSciTech 14(1):254–264. https://doi.org/10.1208/s12249-012-9914-0
Warriner R, Burrell R (2005) Infection and the chronic wound: a focus on silver. Adv Skin Wound Care 18(8):2–12
Wright JB, Lam K, Hansen D, Burrell RE (1999) Efficacy of topical silver against fungal burn wound pathogens. Am J Inf Control 27(4):344–350
Wright J, Lam K, Buret A, Olson M, Burrell R (2002) Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix matalloproteinases, cell apoptosis, and healing. Wound Repair Regeneration, 10:141
Wu J, Zheng Y, Song W, Luan J, Wen X, Wu Z, Chen X, Wang Q, Guo S (2014) In situ synthesis of silver-nanoparticles/bacterial cellulose composites for slow-released antimicrobial wound dressing. Carbohydr Polym 102:762–771
Wu S, Huang J, Zhang F, Qingping W, Zhang J, Pang R, Zeng H, Yang X, Chen M, Wang J, Dai J, Xue L, Lei T, Wei X (2019) Prevalence and characterization of food-related methicillin resistant Staphylococcus aureus (MRSA) in China. Front Microbiol 10:304. https://doi.org/10.3389/fmicb.2019.00304
Wypij M, Świecimska M, Czarnecka J, Dahm H, Rai M, Golińska P (2018) Antimicrobial and cytotoxic activity of silver nanoparticles synthesized from two haloalkaliphilic actinobacterial strains alone and in combination with antibiotics. Appl Microbiol 124:1411–1424
Yin HQ, Langford R, Burrell RE (1999) Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil 20:195–200
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dahm, H. (2020). Silver Nanoparticles in Wound Infections: Present Status and Future Prospects. In: Rai, M. (eds) Nanotechnology in Skin, Soft Tissue, and Bone Infections. Springer, Cham. https://doi.org/10.1007/978-3-030-35147-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-35147-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-35146-5
Online ISBN: 978-3-030-35147-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)